Myriant pulls plug on $125 mln IPO – Fortune

Fortune reported that Myriant has withdrawn its planned $125 million IPO. The publication said that no reasons were given. Based in Quincy, Mass., Myriant is a biochemical company. Its backers include Plainfield Asset Management and PTT Chemical International.

Leave a Reply

PEHUB Community

Join the 12504 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget